Note: “We” and “our” in the text below refer to Pfizer’s Publication Management Team Barriers…
View
Can a data-driven approach that incorporates both traditional and the newer alternative metrics hold the key to improved publication planning, impact and thereby better patient outcomes?
The Altmetric Attention Score could be a singular ‘blueprint’ for tracking attention writes Alex Zhavoronkov in Forbes.
Current data shows that despite a decline in activity, X’s engagement remains higher than pre-COVID levels, underscoring its place in the research discourse.
Can Altmetric solutions provide a clearer picture of how a researcher’s gender might influence their recognition, achievements, and impact within STEM fields? Can Altmetric be one of the means to address current gender disparities within STEM research?
Tools like Altmetric will be vital in tracking the attention research on antimicrobial resistance gets across different information platforms.
While the now well-recognized Altmetric donut does show the amount of attention in various digital settings, it is becoming increasingly clear that digging deeper into Altmetric data can uncover a plethora of important information that was previously difficult, if not impossible, to access.
The emphasis on including patients, families, caregivers, and communities in the discourse means looking beyond research and scholarly circles to understand what themes related to patient safety resonate within the ‘public’ domain
Two recent papers show that the Altmetric Attention Score can have applications pertinent in this era of misinformation in the digital age.
